SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950123-17-010055
Filing Date
2017-11-13
Accepted
2017-11-09 21:00:48
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 apvo-s3.htm S-3 626331
2 EX-4.5 apvo-ex45_46.htm EX-4.5 451120
3 EX-4.8 apvo-ex48_45.htm EX-4.6 156948
4 EX-4.9 apvo-ex49_44.htm EX-4.9 154943
5 EX-4.10 apvo-ex410_249.htm EX-4.10 159358
6 EX-5.1 apvo-ex51_312.htm EX-5.1 49564
7 EX-23.1 apvo-ex231_344.htm EX-23.1 2406
8 GRAPHIC g201711100012363914074.jpg GRAPHIC 4175
9 GRAPHIC g201711100012395062838.jpg GRAPHIC 4497
10 GRAPHIC g201711100012492022839.jpg GRAPHIC 4497
11 GRAPHIC g201711100012513272840.jpg GRAPHIC 4497
  Complete submission text file 0000950123-17-010055.txt   1626635
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221499 | Film No.: 171192554
SIC: 2834 Pharmaceutical Preparations